Towards the Definition of a Prognostic Model for Mantle Cell Lymphoma.

Mantle cell lymphoma (MCL) has a heterogeneous clinical course, making robust, usable prognostic tools essential for risk-adapted care. In this paper, we worked at the definition of an effective and deployable prognostic model, tailored to a specific MCL population. Our work has taken advantage of AutoML-Med, a framework supporting end-users in the data analysis pipeline. Our experiments have provided promising results, leading to an explainable model that outperformed traditional prognostic indexes, paving the way for future investigations.